Quanterix Corp (QTRX) USD0.001

Sell:$6.05Buy:$6.09$0.01 (0.16%)

NASDAQ:0.40%
Prices delayed by at least 15 minutes
Sell:$6.05
Buy:$6.09
Change:$0.01 (0.16%)
Deal now
Prices delayed by at least 15 minutes
Sell:$6.05
Buy:$6.09
Change:$0.01 (0.16%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.

Key people

Masoud Toloue
President, Chief Executive Officer, Director
Vandana Sriram
Chief Financial Officer, Treasurer
William P. Donnelly
Independent Chairman of the Board
Myla P. Laigoldman
Director
Scott Mendel
Director
Jeffrey Thomas Elliott
Independent Director
Ivana Magov Evi-liebisch
Independent Director
Click to see more

Key facts

  • EPIC
    QTRX
  • Location
    United States
  • Sector
    Technology
  • Industry
    Scientific & Technical Instr.
  • ISIN
    US74766Q1013
  • Market cap
    $299.83m
  • Employees
    471
  • Shares in issue
    46.20m
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.